HomeRAPP • NASDAQ
add
Rapport Therapeutics Inc
Previous close
$11.47
Day range
$11.27 - $12.31
Year range
$6.43 - $29.74
Market cap
413.52M USD
Avg Volume
223.79K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 23.52M | 58.99% |
Net income | -19.98M | -47.79% |
Net profit margin | — | — |
Earnings per share | -0.57 | — |
EBITDA | -23.26M | -57.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 305.28M | 107.00% |
Total assets | 314.93M | 102.63% |
Total liabilities | 9.51M | -34.35% |
Total equity | 305.43M | — |
Shares outstanding | 36.50M | — |
Price to book | 1.37 | — |
Return on assets | -18.20% | — |
Return on capital | -18.62% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -19.98M | -47.79% |
Cash from operations | -14.45M | -39.48% |
Cash from investing | 31.93M | 140.59% |
Cash from financing | 7.00K | 105.00% |
Net change in cash | 17.49M | 119.62% |
Free cash flow | -9.05M | — |
About
Founded
2022
Headquarters
Website
Employees
69
